Healthpeak Properties, Inc. (DOC) is a real estate investment trust valued at $11.7 billion, focusing on healthcare properties in Denver, Colorado. However, DOC has underperformed the market, with shares down 20% over the past year. Q2 results showed a revenue decline and a 6.7% stock drop.

Analysts predict a 2.2% FFO growth for DOC this fiscal year, with a history of meeting or exceeding estimates. Despite a slight downgrade in ratings, RBC Capital maintains a “Buy” rating with a $21 price target, indicating a potential 24.6% upside. The mean price target is $22.06, with a high of $29.

Overall, 18 analysts cover DOC, with a consensus “Moderate Buy” rating. Analysts are more bullish on the stock a month ago, with 11 suggesting a “Strong Buy” rating. This information is for informational purposes only.

Read more at Yahoo Finance: Healthpeak Properties Stock: Analyst Estimates & Ratings